<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:55:08Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4246548" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4246548</identifier><datestamp>2014-11-29</datestamp><setSpec>bmccanc</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id>
      <journal-title-group>
        <journal-title>BMC Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4246548</article-id>
      <article-id pub-id-type="pmcid">PMC4246548</article-id>
      <article-id pub-id-type="pmc-uid">4246548</article-id>
      <article-id pub-id-type="pmid">25409685</article-id>
      <article-id pub-id-type="pmid">25409685</article-id>
      <article-id pub-id-type="publisher-id">5032</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2407-14-850</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A DNA repair variant in <italic>POLQ</italic> (c.-1060A &gt; G) is associated to hereditary breast cancer patients: a caseâcontrol study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Brandalize</surname>
            <given-names>Ana Paula Carneiro</given-names>
          </name>
          <address>
            <email>anapaulabrandalize@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SchÃ¼ler-Faccini</surname>
            <given-names>LavÃ­nia</given-names>
          </name>
          <address>
            <email>lavinia.faccini@ufrgs.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoffmann</surname>
            <given-names>Jean-SÃ©bastien</given-names>
          </name>
          <address>
            <email>jean-sebastien.hoffmann@inserm.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caleffi</surname>
            <given-names>Maira</given-names>
          </name>
          <address>
            <email>maira.caleffi@hmv.org.br</email>
          </address>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cazaux</surname>
            <given-names>Christophe</given-names>
          </name>
          <address>
            <email>christophe.cazaux@inserm.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ashton-Prolla</surname>
            <given-names>Patricia</given-names>
          </name>
          <address>
            <email>pprolla@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Laboratory of Medical Genomics, Experimental Research Center, Hospital de ClÃ­nicas de Porto Alegre, Porto Alegre, Brazil </aff>
        <aff id="Aff2"><label/>Department of Genetics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil </aff>
        <aff id="Aff3"><label/>Laboratory of Genomics, Proteomics and DNA Repair, University of Caxias do Sul, Caxias do Sul, Brazil </aff>
        <aff id="Aff4"><label/>Instituto Nacional de GenÃ©tica MÃ©dica Populacional, INAGEMP, Porto Alegre, Brazil </aff>
        <aff id="Aff5"><label/>Equipe Â« LabellisÃ©e Ligue contre le Cancer 2013 Â» INSERM Unit 1037; CNRS ERL 5294, CRCT (Cancer Research Center of Toulouse), Toulouse Oncopole, France </aff>
        <aff id="Aff6"><label/>University of Toulouse; UPS, F-31077 Toulouse, France </aff>
        <aff id="Aff7"><label/>Hospital Moinhos de Vento, Porto Alegre, Brazil </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>850</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Brandalize et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>One of the hallmarks of cancer is the occurrence of high levels of chromosomal rearrangements as a result of inaccurate repair of double-strand breaks (DSB). Germline mutations in <italic>BRCA</italic> and <italic>RAD51</italic> genes, involved in DSB repair, are strongly associated with hereditary breast cancer. Pol Î¸, a translesional DNA polymerase specialized in the replication of damaged DNA, has been also shown to contribute to DNA synthesis associated to DSB repair. It is noteworthy that <italic>POLQ</italic> is highly expressed in breast tumors and this expression is able to predict patient outcome. The objective of this study was to analyze genetic variants related to <italic>POLQ</italic> as new population biomarkers of risk in hereditary (HBC) and sporadic (SBC) breast cancer.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We analyzed through caseâcontrol study nine SNPs of <italic>POLQ</italic> in hereditary (HBC) and sporadic (SBC) breast cancer patients using Taqman Real Time PCR assays. Polymorphisms were systematically identified through the NCBI database and are located within exons or promoter regions. We recruited 204 breast cancer patients (101 SBC and 103 HBC) and 212 unaffected controls residing in Southern Brazil.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The rs581553 SNP located in the promoter region was strongly associated with HBC (c.-1060Aâ&gt;âG; HBC GGâ=â15, Control TTâ=â8; ORâ=â5.67, CI95%â=â2.26-14.20; pâ&lt;â0.0001). Interestingly, 11 of 15 homozygotes for this polymorphism fulfilled criteria for Hereditary Breast and Ovarian Cancer (HBOC) syndrome. Furthermore, 12 of them developed bilateral breast cancer and one had a familial history of bilateral breast cancer. This polymorphism was also associated with bilateral breast cancer in 67 patients (ORâ=â9.86, CI95%â=â3.81-25.54). There was no statistically significant difference of age at breast cancer diagnosis between SNP carriers and non-carriers.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Considering that Pol Î¸ is involved in DBS repair, our results suggest that this polymorphism may contribute to the etiology of HBC, particularly in patients with bilateral breast cancer.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>
          <italic>POLQ</italic>
        </kwd>
        <kwd>DNA repair</kwd>
        <kwd>Breast cancer</kwd>
        <kwd>Translesional DNA polymerase</kwd>
        <kwd>SNP</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Breast cancer is the major cause of cancer death among women worldwide. Although significant progress has been made to increase our knowledge on the mechanisms of carcinogenesis in the breast, the exact steps and contribution of each of these to breast cancer development remain elusive. Among the established risk factors for breast cancer are germline mutations in two highly penetrant genes: <italic>BRCA1</italic> and <italic>BRCA2</italic> [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. These mutations strongly increase breast cancer risk by disrupting homologous recombination repair (HRR) of DNA double strand breaks (DSBs) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Indeed, one of the hallmarks of cancer is the occurrence of high levels of chromosomal rearrangements as a result of inaccurate repair of DSBs [<xref ref-type="bibr" rid="CR5">5</xref>]. Mutations in the <italic>BRCA</italic> genes and other genes encoding proteins involved in DSB repair (i.e. <italic>RAD51</italic>) are mostly associated with hereditary breast cancer and increase the genetic instability caused by DSBs [<xref ref-type="bibr" rid="CR6">6</xref>â<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>DNA polymerase theta (Pol Î¸) is a recently identified translesional polymerase specialized in the replication of damaged DNA, which performs <italic>in vitro</italic> translesion synthesis at an AP sites and thymine glycol lesions. It is likely a major enzyme for such bypass in mammalian cells as it can perform both insertion in front of the damage and extension of the misincorporated nucleotide [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. It is an A-family polymerase composed of 2592 amino acids encoded by <italic>POLQ</italic> (3q13.31). Its function was first identified in <italic>Drosophila</italic>, where the mutant gene <italic>MUS308</italic> (ortholog of <italic>POLQ</italic>) was unable to survive to the chemical agents used to induce DNA breaks [<xref ref-type="bibr" rid="CR11">11</xref>]. This polymerase possesses a unique structure with a conserved helicase domain at its N-terminal region, a polymerase domain at the C-terminus and a long central domain [<xref ref-type="bibr" rid="CR12">12</xref>]. The lack of 3â²-5â² exonuclease activity explains its low fidelity, generating substitutions at a frequency 10 to 100 times higher than observed with other family A polymerases [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>Although the function of PolÎ¸ is not yet fully understood, several studies suggest that it may hold an important role in the maintenance of genome stability [<xref ref-type="bibr" rid="CR14">14</xref>]. Pol Î¸ has been proposed to be a backup DNA polymerase for base excision repair in chicken DT40 cells [<xref ref-type="bibr" rid="CR15">15</xref>] and in nematodes [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. A role in the repair of DSB by performing DNA synthesis during alternative microhomology-mediated end-joining has been shown in <italic>Drosophila</italic> [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] and this potential DNA repair function may explain why mouse Pol Î¸-deficient bone marrow and erythrocyte cells as well as human Pol Î¸-depleted tumor cells show increased sensitivity to ionizing radiation [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. It was also observed that PolÎ¸ possesses a polymerase activity in regions with DSBs [<xref ref-type="bibr" rid="CR12">12</xref>]. <italic>In vitro</italic> studies in different organisms demonstrated that <italic>POLQ</italic> mutations resulted in abnormal DNA repair processes, decreased cell growth rates, arrest in G2 and increased chromosomal breaks and exchanges [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR22">22</xref>].</p>
      <p>In the context of cancer, the up-regulation of <italic>POLQ</italic> is observed in different tumor tissues, including lung, stomach, colon, breast, melanoma and oral squamous cell carcinomas [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>â<xref ref-type="bibr" rid="CR27">27</xref>]. Recently, the expression of 13 human DNA polymerase genes was evaluated in breast carcinomas. Among these, <italic>POLQ</italic> showed the highest level of expression. Interestingly, patients with a more aggressive phenotype of breast cancer (triple negative), also had the highest levels of <italic>POLQ</italic> expression and lower survival (OR = 4.28; pâ=â0.0001), regardless of the levels of <italic>CYCLIN E</italic> and number of positive nodes [<xref ref-type="bibr" rid="CR23">23</xref>]. These results were then confirmed in an independent cohort by Higgins et al. in 2010 (ORâ=â5.80; pâ=â0.001). In addition, fibroblasts transfected with a vector containing <italic>POLQ</italic> led to replicative stress and chromosomal instability [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
      <p>Given the importance of DNA polymerase <italic>POLQ</italic> as genetic signature for the development and progression of breast cancer, the analysis of genetic variants in the <italic>POLQ</italic> gene represents a yet poor explored field of potential biomarkers in patients with breast cancer. Taken into account the possible involvement of <italic>POLQ</italic> in single and/or DSB repair, we hypothesized that variations in this DNA repair gene could drive the development of breast cancer. Here, we evaluated the possible contribution of nine SNPs in the <italic>POLQ</italic> gene to the development of both sporadic and hereditary breast cancer through a caseâcontrol approach.</p>
    </sec>
    <sec id="Sec2" sec-type="methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Subjects</title>
        <p>The subjects included in this study were divided into three groups: (1) Sporadic Breast Cancer (SBC), included women diagnosed with breast cancer above age 50 years who had no family history of breast cancer or other tumors; (2) Hereditary Breast Cancer (HBC), composed by women with a positive family history of breast cancer and other tumors and whose pedigrees met criteria for at least one of the hereditary breast cancer syndromes (HBOC â Hereditary Breast and Ovarian Cancer, HBCC â Hereditary Breast and Colon Cancer, SLF â Li-Fraumeni Syndrome or Li-Fraumeni like Syndrome) and excluding patients with known <italic>BRCA</italic> mutations; and (3) Patients without clinical evidence and/or suspected breast cancer participating in a mammographic screening program with normal (BIRADS 1 or 2) mammography scans within the last 12 months prior to sample collection. Along the study, a decision was made to include a fourth study group, and a cohort of 67 patients with bilateral breast cancer, regardless of age at diagnosis and family history of breast and other cancers was recruited. This study was performed independently of full <italic>BRCA1, BRCA2, TP53</italic> and <italic>CHEK2</italic> genotyping, based on the phenotype and clinical criteria for these syndromes. Thus, information on mutation status for high penetrance breast cancer genes is not available.</p>
        <p>The study was approved by the Research Ethics Committee of Hospital de ClÃ­nicas de Porto Alegre (HCPA; protocol number 11â0328) and informed consent was obtained from all women before recruitment.</p>
      </sec>
      <sec id="Sec4">
        <title>SNP selection</title>
        <p>Nine SNPs were systematically identified through the NCBI SNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp">http://www.ncbi.nlm.nih.gov/snp</ext-link>). SNPs were selected based on likelihood of affecting normal protein function (TableÂ <xref rid="Tab1" ref-type="table">1</xref>), association with an amino acid change in the protein (missense mutation) and location within exons. The most informative TagSNP and polymorphisms located in the putative transcription factor binding sites were identified using S NPinfo (<ext-link ext-link-type="uri" xlink:href="http://www.snpinfo.niehs.nih.gov">http://www.snpinfo.niehs.nih.gov</ext-link>). Missense SNPs were included in our analysis due to their possible effect on protein function. The Polyphen prediction tool was used to predict a possible impact of this substitution. The Regulome DB was used to predict the effect of 5â²UTR SNPs. SNPs with minor allele frequencies (MAF) described as less than 0.1 for European population databases were excluded.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Characteristics of selected</bold>
<bold><italic>POLQ</italic></bold>
<bold>SNPs</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP ID</th><th>Region</th><th>Protein domain</th><th>Mutation type</th><th>Aminoacid change</th><th>Possible functional effect</th></tr></thead><tbody><tr><td>rs587553</td><td align="center">-1060</td><td align="center"/><td align="center"/><td align="center"/><td align="center">Putative TFBS*</td></tr><tr><td>rs13065220</td><td align="center">-190</td><td align="center"/><td align="center"/><td align="center"/><td align="center">Putative TFBS*</td></tr><tr><td>rs3806614</td><td align="center">-323</td><td align="center"/><td align="center"/><td align="center"/><td align="center">Putative TFBS*</td></tr><tr><td>rs11713643</td><td align="center">intron 1</td><td align="center"/><td align="center">TagSNP</td><td align="center"/><td align="center">Tags 23 of 56 SNPs listed at SNP info</td></tr><tr><td>rs41545723</td><td align="center">Exon 4</td><td align="center">helicase</td><td align="center">missense</td><td align="center">Leu197Arg</td><td align="center">possibly damaging**</td></tr><tr><td>rs61757736</td><td align="center">Exon 6</td><td align="center">helicase</td><td align="center">missense</td><td align="center">Ser305Ala</td><td align="center">possibly damaging**</td></tr><tr><td>rs55748151</td><td align="center">Exon 6</td><td align="center">helicase</td><td align="center">missense</td><td align="center">Val310Gly</td><td align="center">possibly damaging**</td></tr><tr><td>rs3218651</td><td align="center">Exon 16</td><td align="center">central</td><td align="center">missense</td><td align="center">His1201Arg</td><td align="center">possibly damaging**</td></tr><tr><td>rs1381057</td><td align="center">Exon 28</td><td align="center">polymerase</td><td align="center">missense</td><td align="center">Gly2513Arg</td><td align="center">possibly damaging**</td></tr></tbody></table><table-wrap-foot><p>*<italic>TFBS</italic>â=âTranscription Binding Factor Site; Functional effect predicted by regulome DB.</p><p>**Funciontal effect predicted by Polyphen.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Genotyping</title>
        <p>Peripheral blood samples collected in EDTA tubes were subjected to DNA extraction using the GE extraction kit (GE Healthcare Lifesciences BR). TaqMan assays were used for SNP genotyping. Genotypes were determined by the TaqMan probes C_88490787-10, C_86270772-10, C_88490786, C_919228-10, C_8248307-20, C_31746782-10, C_3100675-10 and C_61757736. Two custom assays were specially developed, one for the Tag SNP and another for rs11713643 (Applied Biosystems). Real-time PCR reactions were performed in 48-well plates. Briefly, each reaction contained 20ng of genomic DNA, 6.25 Î¼l of 2x MasterMix Genotyping TaqMan (Applied Biosystems), 0.31 Î¼l of probes specific for each polymorphism (40x) and 4.94 Î¼l of DNase-free water. A StepOne PCR Real-Time System was used for all reactions, with an initial cycle of 10 minutes at 95Â°C, followed by 45 cycles of 15 seconds at 92Â°C and 1 minute at 60Â°C.</p>
      </sec>
      <sec id="Sec6">
        <title>Statistical analyses</title>
        <p>The Chi-square test was used to assess deviation from Hardy-Weinberg equilibrium and to compare allele and genotypic frequencies between cases and control groups. For each statistically significant association, an unconditional binary logistic regression model was fitted to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). Statistical analyses were performed using SPSS software version 18.0.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <p>A total of 103 HBC and 101 SBC patients were included in the case groups, and their clinical characteristics are summarized in TableÂ <xref rid="Tab2" ref-type="table">2</xref>. The control group included 212 women unaffected by breast cancer whose mean age was 56 years (SD = 5.8 years).<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Clinical characteristics of HBC and SBC groups</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristic</th><th colspan="3">HBC</th><th rowspan="2">SBC</th></tr><tr><th>HBOC</th><th>HBCC</th><th>Other*</th></tr></thead><tbody><tr><td>Number of patients, n (%)</td><td align="center">77 (74.8)</td><td align="center">4 (3.9)</td><td align="center">22 (21.4)</td><td align="center">101 (100)</td></tr><tr><td>Age at diagnosis, mean (sd)</td><td align="center">45.75 (11.8)</td><td align="center">47.66 (3.2)</td><td align="center">41.1 (10.4)</td><td align="center">56.9 (5.2)</td></tr><tr><td>Age at diagnosis &gt;50, n (%)</td><td align="center">25 (32.5)</td><td align="center">0</td><td align="center">6 (27.3)</td><td align="center">101 (100)</td></tr><tr><td>Bilateral breast cancer, n (%)</td><td align="center">50 (74.6)</td><td align="center">3 (4.5)</td><td align="center">5 (7.5)</td><td align="center">9 (13.4)</td></tr><tr><td>Synchronic</td><td align="center">23 (47.8)</td><td align="center">2 (66.7)</td><td align="center">-</td><td align="center">2 (22.2)</td></tr><tr><td>Metachronic</td><td align="center">26 (50.0)</td><td align="center">0</td><td align="center">-</td><td align="center">7 (77.8)</td></tr><tr><td>Missing</td><td align="center">1 (2.2)</td><td align="center">1 (33.3)</td><td align="center">5 (100)</td><td align="center">0</td></tr></tbody></table><table-wrap-foot><p>*Other: Li-Fraumeni, Li-Fraumeni like or HBCC syndromes.</p></table-wrap-foot></table-wrap></p>
      <p>The observed distribution of <italic>POLQ</italic> genotypes and allele frequencies in all groups, as well as their respective frequencies in 1000 Genomes database are shown in TableÂ <xref rid="Tab3" ref-type="table">3</xref>. Since the geographic region of patient recruitment is extensively colonized by Europeans [<xref ref-type="bibr" rid="CR28">28</xref>], we used the expected allelic frequencies published in 1000 Genomes for euro-descendent populations as reference to minimize effects of population admixture in the analysis. Three of the nine SNPs studied (rs61757736, rs41545723, rs55748151) were not found in any of the groups. The allelic distribution for the other polymorphisms were in Hardy-Weinberg equilibrium in all groups, and the observed allele frequencies in controls are in agreement with those described for euro-descendants in the 1000 Genomes database. Overall, the <italic>POLQ</italic> genotype frequencies were equally distributed in SBC and controls with the exception of rs581553 located in the promoter region of the gene, which was strongly associated with an increased risk for HBC (c.-1060Aâ&gt;âG; HBC GGâ=â15, Control GGâ=â8; ORâ=â5.67, CI95%â=â2.26-14.20; pâ&lt;â0.0001). Specifically rs581553 allele G was associated with HBC as well (ORâ=â2.33, CI95%â=â1.57-3.47; pâ&lt;â0.0001). Surprisingly, presence of the polymorphic allele c.3602G, localized in the central domain of Pol Î¸ was associated with a protective effect for breast cancer in the SBC group (ORâ=â0.59, CI95%â=â0.36-0.96; pâ&lt;â0.027).<table-wrap id="Tab3"><label>Table 3</label><caption><p>
<bold>Genotypic and allelic frequency of selected</bold>
<bold><italic>POLQ</italic></bold>
<bold>polymorphisms in HBC, SBC and control groups</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP ID</th><th rowspan="2">Genotype</th><th colspan="2">HBC</th><th colspan="2">Control</th><th rowspan="2">p</th><th colspan="2">SBC</th><th colspan="2">Control</th><th rowspan="2">p</th><th rowspan="2">1000 Genomes</th></tr><tr><th>nâ=â103</th><th>%</th><th>nâ=â212</th><th>%</th><th>nâ=â101</th><th>%</th><th>nâ=â212</th><th>%</th></tr></thead><tbody><tr><td/><td align="center">AA</td><td align="center">48</td><td align="center">46.60</td><td align="center">110</td><td align="center">51.89</td><td align="center"/><td align="center">44</td><td align="center">43.56</td><td align="center">110</td><td align="center">51.89</td><td align="center"/><td align="center"/></tr><tr><td>rs1381057</td><td align="center">AG</td><td align="center">46</td><td align="center">44.66</td><td align="center">86</td><td align="center">40.57</td><td align="center"/><td align="center">49</td><td align="center">48.51</td><td align="center">86</td><td align="center">40.57</td><td align="center"/><td align="center"/></tr><tr><td>c.7538Aâ&gt;âG</td><td align="center">GG</td><td align="center">9</td><td align="center">8.74</td><td align="center">16</td><td align="center">7.55</td><td align="center">0.675</td><td align="center">8</td><td align="center">7.92</td><td align="center">16</td><td align="center">7.55</td><td align="center">0.372</td><td align="center"/></tr><tr><td/><td align="center">G</td><td align="center">64</td><td align="center">31.07</td><td align="center">118</td><td align="center">27.83</td><td align="center">0.401</td><td align="center">65</td><td align="center">32.18</td><td align="center">118</td><td align="center">27.83</td><td align="center">0.301</td><td align="center">28</td></tr><tr><td/><td align="center">AA</td><td align="center">47</td><td align="center">45.63</td><td align="center">142</td><td align="center">66.98</td><td align="center"/><td align="center">59</td><td align="center">58.42</td><td align="center">142</td><td align="center">66.98</td><td align="center"/><td align="center"/></tr><tr><td>rs587553</td><td align="center">AG</td><td align="center">41</td><td align="center">39.81</td><td align="center">62</td><td align="center">29.25</td><td align="center"/><td align="center">34</td><td align="center">33.66</td><td align="center">62</td><td align="center">29.25</td><td align="center"/><td align="center"/></tr><tr><td>c.-1060Aâ&gt;âG</td><td align="center">GG</td><td align="center">15</td><td align="center">14.56</td><td align="center">8</td><td align="center">3.77</td><td align="center">0.0001<sup>a</sup>
</td><td align="center">8</td><td align="center">7.92</td><td align="center">8</td><td align="center">3.77</td><td align="center">0.172</td><td align="center"/></tr><tr><td/><td align="center">G</td><td align="center">71</td><td align="center">34.47</td><td align="center">78</td><td align="center">18.40</td><td align="center">0.0001<sup>b</sup>
</td><td align="center">50</td><td align="center">24.75</td><td align="center">78</td><td align="center">18.40</td><td align="center">0.072</td><td align="center">19</td></tr><tr><td/><td align="center">AA</td><td align="center">44</td><td align="center">42.72</td><td align="center">108</td><td align="center">50.94</td><td align="center"/><td align="center">44</td><td align="center">43.56</td><td align="center">108</td><td align="center">50.94</td><td align="center"/><td align="center"/></tr><tr><td>rs13065220</td><td align="center">GA</td><td align="center">49</td><td align="center">47.57</td><td align="center">89</td><td align="center">41.98</td><td align="center"/><td align="center">49</td><td align="center">48.51</td><td align="center">89</td><td align="center">41.98</td><td align="center"/><td align="center"/></tr><tr><td>c.-190Gâ&gt;âA</td><td align="center">GG</td><td align="center">10</td><td align="center">9.71</td><td align="center">15</td><td align="center">7.08</td><td align="center">0.355</td><td align="center">8</td><td align="center">7.92</td><td align="center">15</td><td align="center">7.08</td><td align="center">0.473</td><td align="center"/></tr><tr><td/><td align="center">G</td><td align="center">69</td><td align="center">33.49</td><td align="center">119</td><td align="center">28.07</td><td align="center">0.165</td><td align="center">65</td><td align="center">32.18</td><td align="center">119</td><td align="center">28.07</td><td align="center">0.303</td><td align="center">28</td></tr><tr><td/><td align="center">CC</td><td align="center">36</td><td align="center">34.95</td><td align="center">97</td><td align="center">45.75</td><td align="center"/><td align="center">39</td><td align="center">38.61</td><td align="center">97</td><td align="center">45.75</td><td align="center"/><td align="center"/></tr><tr><td>rs3806614</td><td align="center">CT</td><td align="center">54</td><td align="center">52.43</td><td align="center">88</td><td align="center">41.51</td><td align="center"/><td align="center">48</td><td align="center">47.52</td><td align="center">88</td><td align="center">41.51</td><td align="center"/><td align="center"/></tr><tr><td>c.-323Câ&gt;âT</td><td align="center">TT</td><td align="center">13</td><td align="center">12.62</td><td align="center">27</td><td align="center">12.74</td><td align="center">0.153</td><td align="center">14</td><td align="center">13.86</td><td align="center">27</td><td align="center">12.74</td><td align="center">0.487</td><td align="center"/></tr><tr><td/><td align="center">T</td><td align="center">80</td><td align="center">38.84</td><td align="center">142</td><td align="center">33.49</td><td align="center">0.213</td><td align="center">76</td><td align="center">37.62</td><td align="center">142</td><td align="center">33.49</td><td align="center">0.324</td><td align="center">33</td></tr><tr><td/><td align="center">AA</td><td align="center">70</td><td align="center">67.96</td><td align="center">132</td><td align="center">62.26</td><td align="center"/><td align="center">76</td><td align="center">75.25</td><td align="center">132</td><td align="center">62.26</td><td align="center"/><td align="center"/></tr><tr><td>rs3218651</td><td align="center">AG</td><td align="center">28</td><td align="center">27.18</td><td align="center">72</td><td align="center">33.96</td><td align="center"/><td align="center">23</td><td align="center">22.77</td><td align="center">72</td><td align="center">33.96</td><td align="center"/><td align="center"/></tr><tr><td>c.3602Aâ&gt;âG</td><td align="center">GG</td><td align="center">5</td><td align="center">4.85</td><td align="center">8</td><td align="center">3.77</td><td align="center">0.461</td><td align="center">2</td><td align="center">1.98</td><td align="center">8</td><td align="center">3.77</td><td align="center">0.073</td><td align="center"/></tr><tr><td/><td align="center">G</td><td align="center">38</td><td align="center">18.44</td><td align="center">88</td><td align="center">20.75</td><td align="center">0.526</td><td align="center">27</td><td align="center">13.37</td><td align="center">88</td><td align="center">20.75</td><td align="center">0.027<sup>c</sup>
</td><td align="center">28</td></tr><tr><td>tag SNP</td><td align="center">TT</td><td align="center">36</td><td align="center">34.95</td><td align="center">91</td><td align="center">42.92</td><td align="center"/><td align="center">48</td><td align="center">47.52</td><td align="center">91</td><td align="center">42.92</td><td align="center"/><td align="center"/></tr><tr><td>rs11713643</td><td align="center">TC</td><td align="center">51</td><td align="center">49.51</td><td align="center">93</td><td align="center">43.87</td><td align="center"/><td align="center">38</td><td align="center">37.62</td><td align="center">93</td><td align="center">43.87</td><td align="center"/><td align="center"/></tr><tr><td>c.2730Tâ&gt;âC</td><td align="center">CC</td><td align="center">16</td><td align="center">15.53</td><td align="center">28</td><td align="center">13.21</td><td align="center">0.398</td><td align="center">15</td><td align="center">14.85</td><td align="center">28</td><td align="center">13.21</td><td align="center">0.576</td><td align="center"/></tr><tr><td/><td align="center">C</td><td align="center">83</td><td align="center">40.29</td><td align="center">149</td><td align="center">35.14</td><td align="center">0.218</td><td align="center">68</td><td align="center">33.66</td><td align="center">149</td><td align="center">35.14</td><td align="center">0.788</td><td align="center">36</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Ï<sup>2</sup> test, pâ&lt;â0.0001, ORâ=â5.67, CI95%â=â2.26-14.20.</p><p>
<sup>b</sup>Ï<sup>2</sup> test, pâ&lt;â0.0001, ORâ=â2.33, CI95%â=â1.57-3.47.</p><p>
<sup>c</sup>Ï<sup>2</sup> test, pâ&lt;â0.027, ORâ=â0.59, CI95%â=â0.36-0.96.</p></table-wrap-foot></table-wrap></p>
      <p>Based on the strong association identified between <italic>POLQ</italic> c.-1060Aâ&gt;âG (rs581553) and HBC, we carefully reviewed the clinical features of the patients with and without the polymorphic genotype c.-1060GG, in an attempt to find a clue for its possible functional role. Interestingly, 11 of the 15 GG homozygotes fulfilled criteria for HBOC syndrome. Furthermore, 12 of them had been diagnosed with bilateral breast cancer and an additional patient reported a familial history of bilateral breast cancer. To verify whether bilateral breast cancer was associated with this polymorphism we analysed rs581553 in an additional group of 67 patients with bilateral breast cancer and a positive family history of either breast or breast and ovarian cancer. When the genotypic frequencies were compared, a statistically significant association remained (Bilateral Breast Cancer GGâ=â15; ORâ=â9.86, CI95%â=â3.81-25.54; pâ&lt;â0.0001), as shown in TableÂ <xref rid="Tab4" ref-type="table">4</xref>. We did not observe an association between presence of G allele and synchronous or metachronous bilateral breast cancer (pâ=â0.887; data not shown). Finally, we hypothesized that the presence of this polymorphism could facilitate or promote occurrence of early onset breast cancer and analysed a group of patients with early-onset breast cancer (age at diagnosis &lt;40 years) for a potential association of this SNP. No statistically significant association was found (pâ=â0.744; data not shown).<table-wrap id="Tab4"><label>Table 4</label><caption><p>
<bold>Genotypic frequency of</bold>
<bold><italic>POLQ</italic></bold>
<bold>c.-1060Aâ&gt;âG in bilateral breast cancer patients and controls</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP ID</th><th>Genotype</th><th colspan="2">Bilateral</th><th colspan="2">Control</th><th>p</th></tr><tr><th/><th/><th>nâ=â67</th><th>%</th><th>nâ=â212</th><th>%</th><th/></tr></thead><tbody><tr><td>rs587553</td><td align="center">AA</td><td align="center">27</td><td align="center">40.30</td><td align="center">142</td><td align="center">66.98</td><td align="center"/></tr><tr><td/><td align="center">AG</td><td align="center">25</td><td align="center">37.31</td><td align="center">62</td><td align="center">29.25</td><td align="center"/></tr><tr><td/><td align="center">GG</td><td align="center">15</td><td align="center">22.39</td><td align="center">8</td><td align="center">3.77</td><td align="center">0.0001*</td></tr></tbody></table><table-wrap-foot><p>*Ï<sup>2</sup> test, pâ&lt;â0.0001, ORâ=â9.86, CI95%â=â3.81-25.54.</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>Deficient DNA repair is one of the most prominent risk factors for tumor development and genetic variations in DNA repair genes have been shown to play an important role in the carcinogenesis of breast cancer. Several genes are responsible for performing DSB DNA repair, and mutations in <italic>BRCA</italic> genes explain around 30% of all hereditary breast cancers. Some studies indicate that the occurrence of breast cancer in families with no <italic>BRCA</italic> mutations, as our HBC group, could be explained by the existence of low penetrance polymorphisms in several repair genes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Accumulating evidence has suggested a potential role for <italic>POLQ</italic> in mammalian DSB repair. <italic>POLQ</italic> deficient mice show increased sensitivity to low doses of bleomycin in their bone marrow cells [<xref ref-type="bibr" rid="CR20">20</xref>], and the same sensitivity has been observed in human tumor cells exposed to ionizing radiation [<xref ref-type="bibr" rid="CR21">21</xref>]. Furthermore, knockdown of <italic>POLQ</italic> in mouse lymphoma cells increases their sensitivity to etoposide [<xref ref-type="bibr" rid="CR30">30</xref>]. All of these agents are established mutagens that produce DNA DSB. Additional evidence supporting a role of <italic>POLQ</italic> in maintaining genomic stability comes from studies in Chaos-1 mice, where a missense mutation at position 1932 of the <italic>POLQ</italic> gene, is associated with high levels of micronuclei, and increased levels of chromosome breakage. At the same time, <italic>POLQ</italic> seems to have a unique role in DSB repair that complements the recombination machinery regulated by <italic>ATM</italic> in HRR since <italic>POLQ</italic> knockout mice display enhanced chromosome instability in ATM-deficient cells [<xref ref-type="bibr" rid="CR31">31</xref>]. The identification of the human <italic>POLQ</italic> ortholog in mus308/<italic>Drosophila</italic> as well as in mus301/spn-C, which is involved in meiotic DSBs repair and checkpoint activation [<xref ref-type="bibr" rid="CR32">32</xref>], reinforces the potential involvement of <italic>POLQ</italic> in HRR. <italic>POLQ</italic> seems to play an additional role in DSB repair utilizing as substrate DNA by the incorporation of random nucleotide sequences [<xref ref-type="bibr" rid="CR33">33</xref>]. Finally, the tolerance to DSB is not uniquely dependent on the polymerase activity of Pol Î¸. The proteinâs helicase domain is likely involved [<xref ref-type="bibr" rid="CR34">34</xref>]. In Drosophila, <italic>POLQ</italic> acts in this sites where its helicase activity unwinds short stretches of DSBs to expose pre-existing microhomologous sequences that are used to align the broken ends to provide a template for pol Î¸ polymerase activity [<xref ref-type="bibr" rid="CR19">19</xref>]. Definitely, the mechanism in which Pol Î¸ coordinates its polymerase and helicase activities to participate in repair of different types of DNA lesions remains to be determined.</p>
      <p>Here we showed that a specific SNP in the promoter region of <italic>POLQ</italic> is associated the phenotype of hereditary breast and ovarian cancer syndrome and/or with bilateral breast cancer, but not sporadic breast cancer. To the best of our knowledge this study is the first to demonstrate an association between a <italic>POLQ</italic> SNP and increased risk for multiple primary breast tumors. In 2008, a germline frameshift mutation, expected to disrupt the polymerase activity, was identified in one patient with a personal and familial history of breast cancer. The authors also described five missense variants in <italic>POLQ</italic> in other 38 women with SBC, but none of these variants seemed to affect gene function [<xref ref-type="bibr" rid="CR2">2</xref>]. Recently, the effects of 11 <italic>POLQ</italic> SNPs were studied in a population-based series of 783 Swedish breast cancer patients, but no association was observed [<xref ref-type="bibr" rid="CR35">35</xref>]. In agreement with our data, these studies did not find a strong association between SBC and <italic>POLQ</italic> variants probably because different mechanisms influence chromosomal instability and carcinogenesis in sporadic and hereditary breast cancers. The components of genetic susceptibility in SBC, where a highly penetrant germline mutation in a cancer predisposition gene is not identified, are still poorly understood and the environmental aetiological factors definitively contribute to increase the risk. In addition, this and other previous studies of <italic>POLQ</italic> variants are limited in sample size to identify significant associations of lower penetrance variants.</p>
      <p>In favour of a deleterious effect of <italic>POLQ</italic> c.-1060GG, its frequency in controls was relatively low (around 3%) as compared to the frequency in patients with HBC (around 15%). It is also interesting to note that the majority (73.3%) of patients harbouring the homozygous mutant genotype in the HBC group had a personal and family history consistent with HBOC. The development of multiple primary breast tumors (bilateral breast tumor) can be associated to disrupted <italic>POLQ</italic> expression that may be involved in DSB repair. In hereditary cancers, the presence of chromosomal instability is linked to germline mutations in genes associated with DNA DSB or interstrand cross-links repair [<xref ref-type="bibr" rid="CR36">36</xref>]. Such mutations have been previously associated with bilateral breast cancer in several populations [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p>
      <p>According to Regulome DB database (<ext-link ext-link-type="uri" xlink:href="http://regulome.stanford.edu/index">http://regulome.stanford.edu/index</ext-link>), <italic>POLQ</italic> c.-1060Aâ&gt;âG is located in a putative transcription binding factor site of Ying Yang1 protein, encoded by the <italic>YY1</italic> gene. This protein is a ubiquitous, conserved, multifunctional zinc-finger transcription factor that regulates initiation, activation, or repression of transcription from a variety of genes required for cell growth, development, differentiation and tumor suppression [<xref ref-type="bibr" rid="CR39">39</xref>â<xref ref-type="bibr" rid="CR42">42</xref>]. The DNA-binding activity of <italic>YY1</italic> increases dramatically early in S phase [<xref ref-type="bibr" rid="CR43">43</xref>], where <italic>POLQ</italic> would be present to perform its translesion or repair activity. It is notyet known whether <italic>YY1</italic> negatively or positively regulates the expression of <italic>POLQ</italic>. However, the Yin Yang 1 protein positively regulates <italic>BRCA1</italic> and inhibits breast cancer formation [<xref ref-type="bibr" rid="CR41">41</xref>]. On the other hand, <italic>YY1</italic>-deficient spermatocytes show univalent formation, increased aneuploidy, and pachytene cell death, which are likely due to defects in DNA repair [<xref ref-type="bibr" rid="CR44">44</xref>]. Thus, we hypothesize that the presence of <italic>POLQ</italic> c.-1060Aâ&gt;âG SNP prevents Ying Yang-1 binding to its transcription binding site, disrupting <italic>POLQ</italic> expression. This in turn disturbs or diminishes DSB repair, leading to a phenotype of increased chromosomal instability, as observed in <italic>BRCA</italic>-deficient and other hereditary breast cancer phenotypes.</p>
    </sec>
    <sec id="Sec9" sec-type="conclusions">
      <title>Conclusions</title>
      <p>Our data contributes to previous evidence suggesting that downregulation or absence of <italic>POLQ</italic> expression leads to inaccurate DSB repair. Thus <italic>POLQ</italic> could be considered as an important player in breast carcinogenesis, acting in this context as a tumor suppressor gene due to its important role in DNA repair. Further analysis to explain the functional consequences of <italic>POLQ</italic> c.-1060GG on <italic>YY1-</italic>mediated <italic>POLQ</italic> expression and on breast cancer progression are warranted. The whole sequencing of <italic>POLQ</italic> gene and its untranslated regions would also be fundamental to determine whether these inherited genetic variations can predispose women to breast cancer, and particularly to bilateral breast cancer.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>DSB</term>
            <def>
              <p>Double strand breaks</p>
            </def>
          </def-item>
          <def-item>
            <term>HBC</term>
            <def>
              <p>Hereditary breast cancer</p>
            </def>
          </def-item>
          <def-item>
            <term>HBOC</term>
            <def>
              <p>Hereditary breast and ovarian cancer syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>HBCC</term>
            <def>
              <p>Hereditary breast and colon cancer syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>HCPA</term>
            <def>
              <p>Clinical hospital of porto alegre</p>
            </def>
          </def-item>
          <def-item>
            <term>CI95%</term>
            <def>
              <p>Confidence interval</p>
            </def>
          </def-item>
          <def-item>
            <term>HRR</term>
            <def>
              <p>Homologous recombination repair</p>
            </def>
          </def-item>
          <def-item>
            <term>MAF</term>
            <def>
              <p>Minor allele frequencies</p>
            </def>
          </def-item>
          <def-item>
            <term>OR</term>
            <def>
              <p>Odds ratio</p>
            </def>
          </def-item>
          <def-item>
            <term>PCR</term>
            <def>
              <p>Polymerase chain reaction</p>
            </def>
          </def-item>
          <def-item>
            <term>SBC</term>
            <def>
              <p>Sporadic breast cancer</p>
            </def>
          </def-item>
          <def-item>
            <term>SLF</term>
            <def>
              <p>Li-Fraumeni syndrome or li-fraumeni like syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>SNP</term>
            <def>
              <p>Single nucleotide polymorphism</p>
            </def>
          </def-item>
          <def-item>
            <term>UTR</term>
            <def>
              <p>Untranslated region</p>
            </def>
          </def-item>
          <def-item>
            <term>SD</term>
            <def>
              <p>Standard deviation.</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ contributions</bold>
        </p>
        <p>APCB conceived the study, conducted the experiments, analysed data and wrote the manuscript. LSF, JSH and CC participated in its design, helped on the interpretation of the results and revised critically the manuscript. MC recruited and collected the clinical data of breast cancer patients. PP conceived and coordinated the study, analysed the data and helped to draft the manuscript. All authors reviewed and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors would like to thank Dr. Ingrid Petroni Ewald for helping with the recruitment of the bilateral breast cancer patients and the following financial support: INAGEMP â National Institute of Population Medical Genetics (grant CNPq 573993/2008-4), CNPq (grant 484018/2013-2) and FIPE/HCPA (GPPG #11-0328).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hereditary breast and ovarian cancer susceptibility genes (Review)</article-title>
          <source>Oncol Rep</source>
          <year>2013</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>1019</fpage>
          <lpage>1029</lpage>
          <?supplied-pmid 23779253?>
          <pub-id pub-id-type="pmid">23779253</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Amadio</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Thibodeau</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Cerhan</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Couch</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers</article-title>
          <source>Cancer Res</source>
          <year>2008</year>
          <volume>68</volume>
          <issue>4</issue>
          <fpage>971</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6272</pub-id>
          <?supplied-pmid 18281469?>
          <pub-id pub-id-type="pmid">18281469</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jasin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Homologous repair of DNA damage and tumorigenesis: the BRCA connection</article-title>
          <source>Oncogene</source>
          <year>2002</year>
          <volume>21</volume>
          <issue>58</issue>
          <fpage>8981</fpage>
          <lpage>8993</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1206176</pub-id>
          <?supplied-pmid 12483514?>
          <pub-id pub-id-type="pmid">12483514</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>BRCA2 affects the efficiency of DNA double-strand break repair in response to N-nitroso compounds with differing carcinogenic potentials</article-title>
          <source>Oncol Lett</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>6</issue>
          <fpage>1948</fpage>
          <lpage>1954</lpage>
          <?supplied-pmid 23833673?>
          <pub-id pub-id-type="pmid">23833673</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanahan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Hallmarks of cancer: the next generation</article-title>
          <source>Cell</source>
          <year>2011</year>
          <volume>144</volume>
          <issue>5</issue>
          <fpage>646</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>
          <?supplied-pmid 21376230?>
          <pub-id pub-id-type="pmid">21376230</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mohseni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tamaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garay</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Croessmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Karnan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Konishi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Karakas</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tahir</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Abukhdeir</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gustin</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Cidado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Cosgrove</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cochran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jelovac</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Arena</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lauring</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Heaphy</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hosokawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gabrielson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meeker</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Visvanathan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Argani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bachman</surname>
              <given-names>KE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2011</year>
          <volume>108</volume>
          <issue>43</issue>
          <fpage>17773</fpage>
          <lpage>17778</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1110969108</pub-id>
          <?supplied-pmid 21987798?>
          <pub-id pub-id-type="pmid">21987798</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Distinct functions of BRCA1 and BRCA2 in double-strand break repair</article-title>
          <source>Breast Cancer Res</source>
          <year>2002</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1186/bcr417</pub-id>
          <?supplied-pmid 11879553?>
          <pub-id pub-id-type="pmid">11879553</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golmard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Caux-Moncoutier</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Davy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Al Ageeli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Poirot</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tirapo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michaux</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barbaroux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>dâEnghien</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Nicolas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>CastÃ©ra</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sastre-Garau</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Stern</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Houdayer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stoppa-Lyonnet</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Germline mutation in the RAD51B gene confers predisposition to breast cancer</article-title>
          <source>BMC Cancer</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>484</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2407-13-484</pub-id>
          <?supplied-pmid 24139550?>
          <pub-id pub-id-type="pmid">24139550</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Masutani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Schuffert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bahar</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>High-efficiency bypass of DNA damage by human DNA polymerase Q</article-title>
          <source>EMBO J</source>
          <year>2004</year>
          <volume>23</volume>
          <issue>22</issue>
          <fpage>4484</fpage>
          <lpage>4494</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7600424</pub-id>
          <?supplied-pmid 15496986?>
          <pub-id pub-id-type="pmid">15496986</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6â4) photoproduct</article-title>
          <source>DNA Repair (Amst)</source>
          <year>2008</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>119</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dnarep.2007.08.005</pub-id>
          <pub-id pub-id-type="pmid">17920341</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyd</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>PV</given-names>
            </name>
          </person-group>
          <article-title>mus308 mutants of Drosophila exhibit hypersensitivity to DNA cross-linking agents and are defective in a deoxyribonuclease</article-title>
          <source>Genetics</source>
          <year>1990</year>
          <volume>125</volume>
          <issue>4</issue>
          <fpage>813</fpage>
          <lpage>819</lpage>
          <?supplied-pmid 2397884?>
          <pub-id pub-id-type="pmid">2397884</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells</article-title>
          <source>Nucleic Acids Res</source>
          <year>2003</year>
          <volume>31</volume>
          <issue>21</issue>
          <fpage>6117</fpage>
          <lpage>6126</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkg814</pub-id>
          <?supplied-pmid 14576298?>
          <pub-id pub-id-type="pmid">14576298</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arana</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Rogozin</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Kunkel</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Low-fidelity DNA synthesis by human DNA polymerase theta</article-title>
          <source>Nucleic Acids Res</source>
          <year>2008</year>
          <volume>36</volume>
          <issue>11</issue>
          <fpage>3847</fpage>
          <lpage>3856</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkn310</pub-id>
          <?supplied-pmid 18503084?>
          <pub-id pub-id-type="pmid">18503084</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yousefzadeh</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>DNA polymerase POLQ and cellular defense against DNA damage</article-title>
          <source>DNA Repair (Amst)</source>
          <year>2013</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dnarep.2012.10.004</pub-id>
          <pub-id pub-id-type="pmid">23219161</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kohzaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Asagoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sonoda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yasui</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Arakawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Buerstedde</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hochegger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hiraoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage</article-title>
          <source>Mol Cell</source>
          <year>2006</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>115</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2006.07.032</pub-id>
          <?supplied-pmid 17018297?>
          <pub-id pub-id-type="pmid">17018297</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Longley</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sharief</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Human DNA polymerase theta possesses 5â²-dRP lyase activity and functions in single-nucleotide base excision repair in vitro</article-title>
          <source>Nucleic Acids Res</source>
          <year>2009</year>
          <volume>37</volume>
          <issue>6</issue>
          <fpage>1868</fpage>
          <lpage>1877</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkp035</pub-id>
          <?supplied-pmid 19188258?>
          <pub-id pub-id-type="pmid">19188258</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asagoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Braithwaite</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Santana-Santos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Van Houten</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Single-nucleotide base excision repair DNA polymerase activity in C. elegans in the absence of DNA polymerase Î²</article-title>
          <source>Nucleic Acids Res</source>
          <year>2012</year>
          <volume>40</volume>
          <issue>2</issue>
          <fpage>670</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr727</pub-id>
          <?supplied-pmid 21917855?>
          <pub-id pub-id-type="pmid">21917855</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>McVey</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions</article-title>
          <source>Nucleic Acids Res</source>
          <year>2010</year>
          <volume>38</volume>
          <issue>17</issue>
          <fpage>5706</fpage>
          <lpage>5717</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq379</pub-id>
          <?supplied-pmid 20460465?>
          <pub-id pub-id-type="pmid">20460465</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>McVey</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Dual roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila</article-title>
          <source>PLoS Genet</source>
          <year>2010</year>
          <volume>6</volume>
          <issue>7</issue>
          <fpage>e1001005</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1001005</pub-id>
          <?supplied-pmid 20617203?>
          <pub-id pub-id-type="pmid">20617203</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goff</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Epperly</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bakkenist</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Dertinger</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Torous</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Wittschieben</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Greenberger</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation</article-title>
          <source>Radiat Res</source>
          <year>2009</year>
          <volume>172</volume>
          <issue>2</issue>
          <fpage>165</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1667/RR1598.1</pub-id>
          <?supplied-pmid 19630521?>
          <pub-id pub-id-type="pmid">19630521</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Prevo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Helleday</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Muschel</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hickson</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Bernhard</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WG</given-names>
            </name>
          </person-group>
          <article-title>A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown</article-title>
          <source>Cancer Res</source>
          <year>2010</year>
          <volume>70</volume>
          <issue>7</issue>
          <fpage>2984</fpage>
          <lpage>2993</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-4040</pub-id>
          <?supplied-pmid 20233878?>
          <pub-id pub-id-type="pmid">20233878</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muzzini</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Plevani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Cassata</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Caenorhabditis elegans POLQ-1 and HEL-308 function in two distinct DNA interstrand cross-link repair pathways</article-title>
          <source>DNA Repair (Amst)</source>
          <year>2008</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>941</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="doi">10.1016/j.dnarep.2008.03.021</pub-id>
          <pub-id pub-id-type="pmid">18472307</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LemÃ©e</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bergoglio</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Fernandez-Vidal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Machado-Silva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pillaire</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bieth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gentil</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Leduc</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leduc</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Magdeleine</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Filleron</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oumouhou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kaina</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grimal</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lacroix-Triki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>RochÃ©</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bourdon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Cazaux</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2010</year>
          <volume>107</volume>
          <issue>30</issue>
          <fpage>13390</fpage>
          <lpage>13395</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0910759107</pub-id>
          <?supplied-pmid 20624954?>
          <pub-id pub-id-type="pmid">20624954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillaire</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Selves</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gordien</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gourraud</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Gouraud</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Gentil</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Danjoux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Do</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Negre</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bieth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guimbaud</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Trouche</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pasero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>MÃ©chali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Cazaux</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A âDNA replicationâ signature of progression and negative outcome in colorectal cancer</article-title>
          <source>Oncogene</source>
          <year>2010</year>
          <volume>29</volume>
          <issue>6</issue>
          <fpage>876</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2009.378</pub-id>
          <?supplied-pmid 19901968?>
          <pub-id pub-id-type="pmid">19901968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lessa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>de Freitas</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Kowalski</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Vettore</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Identification of upregulated genes in oral squamous cell carcinomas</article-title>
          <source>Head Neck</source>
          <year>2012</year>
          <volume>35</volume>
          <issue>10</issue>
          <fpage>1475</fpage>
          <lpage>1481</lpage>
          <?supplied-pmid 22987617?>
          <pub-id pub-id-type="pmid">22987617</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allera-Moreau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rouquette</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lepage</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Oumouhou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Walschaerts</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leconte</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gordien</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brouchet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Delisle</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sakiyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O-Wang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients</article-title>
          <source>Oncogenesis</source>
          <year>2012</year>
          <volume>1</volume>
          <fpage>e30</fpage>
          <pub-id pub-id-type="doi">10.1038/oncsis.2012.29</pub-id>
          <?supplied-pmid 23552402?>
          <pub-id pub-id-type="pmid">23552402</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bahar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seimiya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chiyo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hatano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tokuhisa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sakiyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O-Wang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers</article-title>
          <source>Int J Cancer</source>
          <year>2004</year>
          <volume>109</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.11666</pub-id>
          <?supplied-pmid 14735462?>
          <pub-id pub-id-type="pmid">14735462</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paskulin</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Cunha-Filho</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bortolini</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Hainaut</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ashton-Prolla</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure</article-title>
          <source>Cell Death Dis</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>e392</fpage>
          <pub-id pub-id-type="doi">10.1038/cddis.2012.116</pub-id>
          <?supplied-pmid 23013791?>
          <pub-id pub-id-type="pmid">23013791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matta</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Echenique</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Negron</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gaetan</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Lizardi</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rosado</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>BolaÃ±os</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Laboy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Medina</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dutil</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alvarez-Garriga</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bayona</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The association of DNA repair with breast cancer risk in women. A comparative observational study</article-title>
          <source>BMC Cancer</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>490</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2407-12-490</pub-id>
          <?supplied-pmid 23088658?>
          <pub-id pub-id-type="pmid">23088658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ukai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maruyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mochizuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ouchida</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tagawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tokuhisa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O-Wang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Role of DNA polymerase theta in tolerance of endogenous and exogenous DNA damage in mouse B cells</article-title>
          <source>Genes Cells</source>
          <year>2006</year>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>111</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2443.2006.00922.x</pub-id>
          <?supplied-pmid 16436048?>
          <pub-id pub-id-type="pmid">16436048</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shima</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Munroe</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Schimenti</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <issue>23</issue>
          <fpage>10381</fpage>
          <lpage>10389</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.24.23.10381-10389.2004</pub-id>
          <?supplied-pmid 15542845?>
          <pub-id pub-id-type="pmid">15542845</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laurencon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orme</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Boulton</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Vladar</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Langley</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Bakis</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Wayson</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hawley</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Burtis</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>A large-scale screen for mutagen-sensitive loci in Drosophila</article-title>
          <source>Genetics</source>
          <year>2004</year>
          <volume>167</volume>
          <issue>1</issue>
          <fpage>217</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1534/genetics.167.1.217</pub-id>
          <?supplied-pmid 15166149?>
          <pub-id pub-id-type="pmid">15166149</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hogg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>DoubliÃ©</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Lesion bypass activity of DNA polymerase Î¸ (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts</article-title>
          <source>J Mol Biol</source>
          <year>2011</year>
          <volume>405</volume>
          <issue>3</issue>
          <fpage>642</fpage>
          <lpage>652</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2010.10.041</pub-id>
          <?supplied-pmid 21050863?>
          <pub-id pub-id-type="pmid">21050863</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JY</given-names>
            </name>
          </person-group>
          <article-title>Comparison of two POLQ mutants reveals that a polymerase-inactive POLQ retains significant function in tolerance to etoposide and Î³-irradiation in mouse B cells</article-title>
          <source>Genes Cells</source>
          <year>2011</year>
          <volume>16</volume>
          <issue>9</issue>
          <fpage>973</fpage>
          <lpage>983</lpage>
          <?supplied-pmid 21883722?>
          <pub-id pub-id-type="pmid">21883722</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varadi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bevier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grzybowska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Enquist</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Henriksson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Butkiewicz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pamula-Pilat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tecza</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hemminki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lenner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>FÃ¶rsti</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Genetic variation in genes encoding for polymerase Î¶ subunits associates with breast cancer risk, tumour characteristics and survival</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2011</year>
          <volume>129</volume>
          <issue>1</issue>
          <fpage>235</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-011-1460-z</pub-id>
          <?supplied-pmid 21455670?>
          <pub-id pub-id-type="pmid">21455670</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deniz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Holzmann</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>WiesmÃ¼ller</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Functional analysis-make or break for cancer predictability</article-title>
          <source>Mutat Res</source>
          <year>2013</year>
          <volume>743â744</volume>
          <fpage>132</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mrfmmm.2013.03.009</pub-id>
          <?supplied-pmid 23541693?>
          <pub-id pub-id-type="pmid">23541693</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Katagiri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kurumizaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kasumi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Akiyama</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nagawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miki</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Identification of Rad51 alteration in patients with bilateral breast cancer</article-title>
          <source>J Hum Genet</source>
          <year>2000</year>
          <volume>45</volume>
          <issue>3</issue>
          <fpage>133</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="doi">10.1007/s100380050199</pub-id>
          <?supplied-pmid 10807537?>
          <pub-id pub-id-type="pmid">10807537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Casado</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fernandez-Serra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Llopis</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Llombart</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lopez-Guerrero</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer</article-title>
          <source>BMC Med Genet</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>134</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2350-12-134</pub-id>
          <?supplied-pmid 21989022?>
          <pub-id pub-id-type="pmid">21989022</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassardjian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rizkallah</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Renfro</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Hurt</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>The transcription factor YY1 is a novel substrate for Aurora B kinase at G2/M transition of the cell cycle</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>11</issue>
          <fpage>e50645</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0050645</pub-id>
          <?supplied-pmid 23226345?>
          <pub-id pub-id-type="pmid">23226345</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hwang</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YU</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Souabni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Busslinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Transcription factor YY1 is essential for regulation of the Th2 cytokine locus and for Th2 cell differentiation</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2013</year>
          <volume>110</volume>
          <issue>1</issue>
          <fpage>276</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1214682110</pub-id>
          <?supplied-pmid 23248301?>
          <pub-id pub-id-type="pmid">23248301</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Lahusen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>CX</given-names>
            </name>
          </person-group>
          <article-title>Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation</article-title>
          <source>Oncogene</source>
          <year>2012</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>116</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2011.217</pub-id>
          <?supplied-pmid 21666725?>
          <pub-id pub-id-type="pmid">21666725</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kasim</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kano</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miyata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Matsuhashi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>UI</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kataoka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyagishi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1Î± in a p53-independent manner</article-title>
          <source>Cancer Res</source>
          <year>2013</year>
          <volume>73</volume>
          <issue>6</issue>
          <fpage>1787</fpage>
          <lpage>1799</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-0366</pub-id>
          <?supplied-pmid 23328582?>
          <pub-id pub-id-type="pmid">23328582</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palko</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bass</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Beyrouthy</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hurt</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase</article-title>
          <source>J Cell Sci</source>
          <year>2004</year>
          <volume>117</volume>
          <issue>Pt 3</issue>
          <fpage>465</fpage>
          <lpage>476</lpage>
          <?supplied-pmid 14702388?>
          <pub-id pub-id-type="pmid">14702388</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Loss of YY1 impacts the heterochromatic state and meiotic double-strand breaks during mouse spermatogenesis</article-title>
          <source>Mol Cell Biol</source>
          <year>2009</year>
          <volume>29</volume>
          <issue>23</issue>
          <fpage>6245</fpage>
          <lpage>6256</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.00679-09</pub-id>
          <?supplied-pmid 19786570?>
          <pub-id pub-id-type="pmid">19786570</pub-id>
        </element-citation>
      </ref>
      <ref-list id="BSec1">
        <title>Pre-publication history</title>
        <ref id="CR45">
          <mixed-citation publication-type="other">The pre-publication history for this paper can be accessed here:<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/14/850/prepub">http://www.biomedcentral.com/1471-2407/14/850/prepub</ext-link></mixed-citation>
        </ref>
      </ref-list>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>